ANI Pharmaceuticals, Inc. (ANIP)
72.66
-0.58
(-0.80%)
USD |
NASDAQ |
Sep 01, 12:01
ANI Pharmaceuticals Net Income (TTM) : 99.95M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.95M |
| March 31, 2026 | 84.68M |
| December 31, 2025 | 71.37M |
| September 30, 2025 | 35.70M |
| June 30, 2025 | -12.60M |
| March 31, 2025 | -22.61M |
| December 31, 2024 | -20.33M |
| September 30, 2024 | -8.896M |
| June 30, 2024 | 25.21M |
| March 31, 2024 | 33.74M |
| December 31, 2023 | 18.78M |
| September 30, 2023 | 13.38M |
| June 30, 2023 | -5.159M |
| March 31, 2023 | -26.33M |
| December 31, 2022 | -47.90M |
| September 30, 2022 | -67.79M |
| June 30, 2022 | -63.64M |
| March 31, 2022 | -62.82M |
| December 31, 2021 | -42.60M |
| September 30, 2021 | -22.10M |
| June 30, 2021 | -17.23M |
| March 31, 2021 | -15.46M |
| December 31, 2020 | -22.56M |
| September 30, 2020 | -23.68M |
| June 30, 2020 | -20.27M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.457M |
| December 31, 2019 | 5.994M |
| September 30, 2019 | 16.13M |
| June 30, 2019 | 17.28M |
| March 31, 2019 | 13.55M |
| December 31, 2018 | 15.35M |
| September 30, 2018 | 0.407M |
| June 30, 2018 | 0.106M |
| March 31, 2018 | 0.018M |
| December 31, 2017 | -1.078M |
| September 30, 2017 | 7.42M |
| June 30, 2017 | 5.261M |
| March 31, 2017 | 3.717M |
| December 31, 2016 | 3.915M |
| September 30, 2016 | 7.855M |
| June 30, 2016 | 9.858M |
| March 31, 2016 | 12.29M |
| December 31, 2015 | 15.30M |
| September 30, 2015 | 33.37M |
| June 30, 2015 | 35.50M |
| March 31, 2015 | 29.59M |
| December 31, 2014 | 28.57M |
| September 30, 2014 | 11.01M |
| June 30, 2014 | 5.391M |
| March 31, 2014 | 3.171M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Viatris, Inc. | -410.70M |
| Liquidia Corp. | 138.61M |
| Elanco Animal Health, Inc. | -199.00M |
| Harmony Biosciences Holdings, Inc. | 181.27M |
| Corcept Therapeutics, Inc. | 54.20M |